Mogrify Ltd is expanding its scientific advisory board with the appointment of three academic experts in the field of cell therapy. They are Christine Mummery, a professor of developmental biology at Leiden University Medical Center in the Netherlands; Graziella Pellegrini, head of the cell therapy programme at the University of Modena and Reggio Emilia in Italy; and Giulio Cossu, professor of regenerative medicines at the University of Manchester in the UK. Profs Mummery, Pellegrini and Cossu will help Mogrify drive its cell conversion technology from proof of concept, through the clinic, and to registration.
Mogrify announced the appointments on 2 November 2020.
Copyright 2020 Evernow Publishing Ltd.